Translating the Latest and Greatest Advances in PAH Into Clinical Practice
Program Goals
Determinants of Prognosis in PAH
Risk Stratification and Assessment
COMPERA Registry
French Registry
French Registry (cont)
French Registry: Survival Based on Number of Low-Risk Criteria Achieved at First Evaluation
REVEAL: Updated PAH Risk Score
REVEAL: Updated PAH Risk Score (cont)
Risk Assessment at Baseline Is Important
French Registry: BNP Subset Analysis
Treatment Considerations
More Complex PAH
Monotherapy vs Initial Combination Therapy?
Role of Monotherapy Today
Role of Monotherapy Today (cont)
Clinical Follow-Up of Patients With PAH
Treatment Follow-Up
Follow-Up
Thresholds for Escalating Therapy
Initial Triple Therapy
Concluding Remarks
Abbreviations
Abbreviations (cont)
Abbreviations (cont)